Press Room

Press Room

Press release

Mictoryl® Pediatric (propiverine hydrochloride) now covered by several public drug plans to treat symptoms associated with overactive bladder

Read more >
Press release

Mictoryl® and Mictoryl® Pediatric now available and distributed in Canada by Duchesnay

Read more >
Press release

Duchesnay Expands its Women’s Health Product Portfolio with Acquisition of Osphena® from Shionogi Inc.

Read more >
Press release

Duchesnay Inc. is pleased to announce that Health Canada has granted market authorization for Mictoryl®/Mictoryl® Pediatric

Read more >
Press release

Duchesnay Summarizes Comprehensive Body of Evidence for Most Studied Morning Sickness Drug Worldwide – Over 40 years of clinical experience, 16 cohort studies, two meta-analyses support regulatory approvals and guidelines –

Read more >